Apotex is transforming osteoporosis care across Canada with Health Canada’s green light for DENOZA™, a cutting-edge denosumab biosimilar. This thrilling launch promises to make treatment more accessible and affordable for patients everywhere!
Browsing: Pharmaceutical Approval